Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Digital Measurement of Subjective Experiences in AD/ADRD
Colin Depp;
Jason Holden;
Eric Granholm
ABSTRACT
Subjective experiences of well-being, emotions, pain, and loneliness are a primary concern of persons living with Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) and their caregivers. Reliable and valid measurement approaches are critical to quantifying these inner processes in treatment studies, but AD/ADRD produce substantial roadblocks to self-report measures of subjective experiences. Technological approaches to gathering passive sensing data about subjective experiences have recently been developed. A promise of passive sensors is their capacity to gather continuous information that could be used to understand within-person dynamics of subjective experiences, and ultimately to better personalize interventions to unique timings and contexts. While there is much enthusiasm about the potential for such measurement tools, there remain a number of challenges (and opportunities for innovation) to generate useful passive measurement tools in AD/ADRD. We briefly summarize some of these challenges and provide suggestions for future innovators in this area.
Citation
Please cite as:
Depp C, Holden J, Granholm E
Digital Measurement of Subjective Experiences in Alzheimer Disease and Related Dementias (AD/ADRD)